Ergoteles LLC Beyond Spring Inc. Transaction History
Ergoteles LLC
- $68.2 Billion
- Q3 2023
Shares
2 transactions
Others Institutions Holding BYSI
# of Institutions
22Shares Held
5.77MCall Options Held
53.2KPut Options Held
2.5K-
Decheng Capital LLC Menlo Park, CA4.96MShares$11.7 Million3.65% of portfolio
-
Citigroup Inc454KShares$1.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$506,0840.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$69,2610.17% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$57,2640.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $91.5M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...